Afuco™ Anti-Human Cell Death Inducing Molecule ADCC Therapeutic Antibody (IGM-55.5), ADCC Enhanced

Anti-Cell Death Inducing Molecule ADCC Enhanced Antibody (IGM-55.5) is an ADCC enhanced antibody produced by our Afuco™ platform. IGM-55.5 is a novel monoclonal human recombinant IgM antibody with potent activity against B cell leukemia and lymphoma.
Supplier Creative Biolabs
Product # AFC-148CL
Pricing Inquiry
Host Human
Target Cell Death Inducing Molecule
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at -20°C. Open under aseptic conditions.
Feedback